Ignite Creation Date:
2024-05-06 @ 3:19 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04595565
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-17
First Post:
2020-04-07
Brief Title:
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
Sponsor:
German Breast Group
Organization:
German Breast Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-28
Start Date Type:
ACTUAL
Primary Completion Date:
2027-03-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-04-07
First Submit QC Date:
October 14 2020
Study First Post Date:
2020-10-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-14
Last Update Post Date:
2024-06-17
Last Update Post Date Type:
ACTUAL